EFM
OLMA icon

E Fund Management’s Olema Pharmaceuticals OLMA Stock Holding History

E Fund Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247K Buy
+16,533
New +$368K 0.01% 421
2024
Q2 		– Sell
-13,927
Closed -$158K – 356
2024
Q1 		$158K Buy
+13,927
New +$180K 0.01% 359

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

E Fund Management's OLMA Position: Q1 2026 in Review

E Fund Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 16,533 shares worth $247K. The stake represents 0.01% of the portfolio and ranks #421 among its holdings. This is a return to the name: E Fund Management previously reported a position in OLMA as recently as Q1 2024.

E Fund Management first reported a position in OLMA in Q1 2024 and has held it in 2 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • E Fund Management held 16,533 shares of Olema Pharmaceuticals worth $247K as of Q1 2026.
  • Olema Pharmaceuticals was a new E Fund Management position in Q1 2026.
  • Olema Pharmaceuticals made up 0.01% of E Fund Management's portfolio in Q1 2026, its #421 holding.
  • E Fund Management first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 2 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.